Abstract Introduction The Randomized Aldactone Evaluation Study (RALES) randomized 822 patients to receive 25 mg spironolactone daily and 841 to receive placebo. The primary endpoint was death from all causes. Randomization began on March 24. 1995; recruitment was completed on December 31. https://parisnaturalfoodes.shop/product-category/raw-chlorella-powder/